Belsomra Tablets 20mg 100tab.
272 $
Find the best price
Dosage form
Belsomra is available as film-coated tablets in the following dosages:
- 5 mg
- 10 mg
- 15 mg
- 20 mg
Please note that the appearance of the packaging may vary depending on the manufacturer and region of sale.
Active ingredient
Suvorexant
Dosage
- Initial dose: The recommended initial dose is 10 mg taken 30 minutes before bedtime. After taking it there should be at least 7 hours before the time of awakening.
- Maximum dose: If necessary, the dose can be increased to 20 mg per day, depending on tolerability and efficacy. The tablets are taken once daily and eating may delay the onset of action of the drug.
Before using Belsomra, consultation with a physician is recommended to select an appropriate dosage and to take into account contraindications or possible interactions with other drugs.
Belsomra
Belsomra (active ingredient: suvorexant) is a medication designed for the treatment of insomnia, characterized by difficulty initiating or maintaining sleep.
Indications for Use:
- Treatment of insomnia in adult patients.
Contraindications:
- Severe hepatic impairment.
- Narcolepsy or cataplexy.
- Concurrent use with strong inhibitors of the CYP3A enzyme.
- Concurrent use with other medications indicated for insomnia.
- Pregnancy and breastfeeding (use only if prescribed by a healthcare professional, considering potential benefits and risks).
- Pediatric patients under 18 years of age.
- Known hypersensitivity to suvorexant or any components of the formulation.
Side Effects:
- Headache.
- Somnolence (excessive drowsiness).
- Dizziness.
- Diarrhea.
- Xerostomia (dry mouth).
- Vivid or unusual dreams.
Precautions:
Before initiating treatment with Belsomra, consultation with a healthcare provider is essential to determine the appropriate dosage and assess potential risks. This medication should be used under the supervision of a medical professional.
